This methodology has been effective in uncovering optimal drug targets in various contexts, including previously established targets for breast cancer (e.g., SRC, MTOR) (17) and spinal cord injury (e.g., TNF, FOS, IL6) (18). The gene discussed is IL6; the disease is breast cancer.